The procholinergic effects of the atypical antipsychotic olanzapine are independent of muscarinic autoreceptor inhibition.
Tzavara
E T
ET
Bymaster
F P
FP
Nomikos
G G
GG
D000109:Acetylcholine / Q000378:metabolism*; D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology*; D017660:Autoreceptors / Q000037:antagonists & inhibitors*; D001569:Benzodiazepines / Q000494:pharmacology; D018678:Cholinergic Agents / Q000494:pharmacology*; D003024:Clozapine / Q000494:pharmacology; D003071:Cognition / Q000187:drug effects*; D006624:Hippocampus / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D008568:Memory / Q000187:drug effects; D051379:Mice; D018345:Mice, Knockout; D017551:Microdialysis; D018727:Muscarinic Antagonists / Q000494:pharmacology*; D000077152:Olanzapine; D043585:Receptor, Muscarinic M2 / Q000037:antagonists & inhibitors* / Q000172:deficiency / Q000235:genetics; D043587:Receptor, Muscarinic M3 / Q000037:antagonists & inhibitors* / Q000172:deficiency / Q000235:genetics; D043588:Receptor, Muscarinic M4 / Q000037:antagonists & inhibitors* / Q000172:deficiency / Q000235:genetics; D012601:Scopolamine / Q000494:pharmacology
D014150:Antipsychotic Agents; D017660:Autoreceptors; D018678:Cholinergic Agents; D018727:Muscarinic Antagonists; D043585:Receptor, Muscarinic M2; D043587:Receptor, Muscarinic M3; D043588:Receptor, Muscarinic M4; D001569:Benzodiazepines; D012601:Scopolamine; D003024:Clozapine; D000077152:Olanzapine; D000109:Acetylcholine